skip to Main Content
Let's Win, Lustgarten Foundation, and AACR logos

2022 AACR Annual Meeting Update

The 2022 AACR meeting featured pancreatic cancer research in artificial intelligence, screening and earlier detection, and vaccines.

pancreatic cancer patient Elizabeth O'Connor and her family at the 2021 World Series

Cherishing the Simple Things

Elizabeth O’Connor has a PALB2 genetic mutation so her stage IV pancreatic cancer has responded to immunotherapy.

ASCO GI and Let's Win logos

A Report from ASCO GI 2022

Clinical trials were reported on at ASCO GI 2022, as well as reports on COVID, virtual tumor boards, and racial disparities in treatment.

pancreatic cancer researcher Wungki Park, M.D.

Claudin May Be the Next Big Target in Pancreatic Cancer Treatment

While immunotherapy and other targeted treatments involving monoclonal antibodies have been successful in other cancers, pancreatic cancer has been notoriously tough to target because of a lack of suitable cell surface targets to which the antibodies can bind. But a new target has been identified, and researchers are hopeful that an investigational drug that homes…

Back To Top